Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
ACADIA Pharmaceuticals Inc. logo

ACADIA Pharmaceuticals Inc.

Sector: Healthcare   

Industry: Biotechnology

18.48
 
USD
  
-0.25
  
(-1.33%)
Optionable: Yes  Market Cap: 3,292 M  90-day average vol: 1,843,375

Previous close: 18.73  Open: 18.62  Bid: 18.49  Ask: 18.58
52 week range    
17.71   
   33.99
Peers   
VNDA / 
BMY / 
PFE / 
JNJ / 
Last updated: Monday 18th March 2024
48
MarketXLS Rank
45
Value
30
Technical
71
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

BMY

0.0332145 B-27.366.19

JNJ

0.0247450 B22.1171.06

LLY

0.0161238 B37.4243.55

PFE

0.0302298 B15.153.21

VNDA

1 B25.313.055
Financials

ACAD Income Statement

Annual
Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
Amortization of intangibles-985000.0-1 M-1 M-1 M1 M1 M
Basic EPS from continuing operations-1.79-1.05
Basic EPS total-1.79-1.05-1.34
Basic weighted shares outstanding86 M97 M101 M116 M123 M127 M147 M157 M160 M161683.0
Cost of sales3 M-3 M-9 M-12 M20 M10 M11 M-10 M
Depreciation-206000.0-647000.0-843000.0-1 M-1 M-1 M2 M2 M-2 M
Depreciation unreconciled-79000.0-206000.0
DepreciationAndAmortization-79000.0-206000.0-647000.0-843000.0-1 M-1 M-1 M2 M2 M-2 M
Diluted EPS total-0.44-0.95-1.63-2.34-2.36-1.94-1.6-1.79-1.05-1.34
Diluted normalized net income/share-1.6
Diluted weighted shares outstanding86 M97 M101 M116 M123 M126 M147 M157 M160 M161683.0
Earnings from equity interest-281 M-168 M-213 M
EarningsFromEquityInterestNetOfTax-281 M-168 M-213 M
GainOnSaleOfPPE10000.03 M
GainOnSaleOfSecurity-2 M997000.0-997000.02 M4 M
GeneralAndAdministrativeExpense13 M33 M-3 M-3 M-4 M-4 M389 M396 M
Gross operating profit1 M120000.0-2 M13 M-13 M205 M319 M432 M473 M507 M
Income before tax-38 M-92 M-164 M-270 M-288 M-244 M-234 M-281 M-168 M-213 M
Income taxes-426000.0330000.01 M1 M1 M876000.0611000.0351000.03 M
Interest income349000.0755000.0499000.03 M4 M5 M11 M7 M591000.07 M
MiscOtherSpecialCharges125 M-2 M997000.0-997000.02 M4 M
Net income from total operations-38 M-92 M-164 M-271 M-289 M-245 M-235 M-282 M-168 M-216 M
NetIncomeCommonStockholders-38 M-92 M-164 M-271 M-289 M-245 M-235 M-261 M-151 M-216 M
NetIncomeContinuousOperations-38 M-92 M-164 M-271 M-289 M-245 M-235 M-282 M-168 M-216 M
NetIncomeDiscontinuousOperations3 M40000.072000.0200000.0400000.02 M200000.0100000.0
NetNonOperatingInterestIncomeExpense349000.0755000.0499000.03 M4 M5 M11 M7 M591000.07 M
Operating income-38 M-93 M-165 M-273 M-417 M-247 M-247 M-287 M-170 M-224 M
Operating income before depreciation (EBITDA)-36 M-92 M-166 M-268 M-286 M-242 M-235 M-277 M-162 M-214 M
OperatingExpense-39 M-93 M162 M286 M404 M453 M566 M708 M635 M731 M
Other income net-10000.0-125 M2 M-997000.0997000.0-2 M-4 M
OtherGandA13 M33 M-3 M-3 M-4 M-4 M389 M396 M
OtherOperatingExpenses-2 M-363000.0-361000.0-5 M-5 M-3 M-4 M-8 M
OtherWriteOff-100000.0
PromotionAndAdvertising-2 M-16 M-40 M-38 M51 M2 M-5 M
ProvisionForGainLossOnDisposal3 M40000.072000.0200000.0400000.02 M200000.0100000.0
RentAndLandingFees13 M33 M-3 M-3 M-4 M-4 M
Research & development expense27 M61 M74 M99 M149 M187 M240 M319 M239 M362 M
ResearchExpense27 M61 M74 M99 M149 M187 M240 M319 M239 M362 M
Revenue per share-985000.0-1 M-1 M-1 M1 M1 M
SalariesAndWages-6 M-16 M-40 M-55 M-76 M-82 M-82 M600000.0-68 M
Selling Gen & administrative expense13 M33 M88 M186 M255 M266 M326 M389 M396 M369 M
SellingAndMarketingExpense88 M186 M255 M266 M326 M51 M2 M369 M
SellingExpense88 M186 M255 M266 M326 M369 M
Total Income available for interest expense (EBIT)-38 M-92 M-164 M-270 M-288 M-244 M-234 M-281 M-168 M-213 M
Total common shares outstanding91 M100 M113 M121 M125 M144 M155 M160 M161 M162 M
Total net income-38 M-92 M-164 M-271 M-289 M-245 M-235 M-282 M-168 M-216 M
Total ordinary shares164 M164 M164 M164 M164 M164 M164 M164 M164 M164 M
Total revenues1 M120000.061000.017 M125 M224 M339 M442 M484 M517 M
TotalExpenses-39 M-93 M165 M283 M395 M441 M586 M718 M646 M720 M
TotalRevenue1 M120000.061000.017 M125 M224 M339 M442 M484 M517 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University